Pancreatic Cancer Symposium (RP2404B)
Dallas, TX US | April 13, 2024
Venue | Faculty | Accreditation | Register/Take course
Available credit:
6.50 AMA
6.50 Attendance
Course opens: 02/19/2024
Course expires: 04/12/2025
Event starts: 04/13/2024 - 8:00am CDT
Event ends: 04/13/2024 - 5:00pm CDT
Download Conference Agenda HERE.
The UTSW Pancreatic Cancer Program Symposium will be a unique opportunity for community cancer care specialists to obtain up-to-date information on novel treatment approaches from UTSW specialists as well as internationally recognized faculty. As the only NCI-Comprehensive Cancer Center in North Texas, UTSW-Simmons Cancer Center carries a vast expertise in the complex management of pancreatic cancer and the responsibility to educate the medical community and increase access to specialized care for this aggressive malignancy. The educational content will include: novel neoadjuvant therapy protocols, use of minimally invasive and robotic techniques for pancreatic cancer and systemic therapy options and trials for advanced disease, among others.
Target Audience
This activity is designed for medical oncologists, surgical oncologists, hepatobiliary surgeons, gastroenterologists, internal medicine physicians, family practice physicians, advanced practice providers, and other health care providers with an interest in pancreatic malignancies.
Learning Objectives
- Identify and discuss the barriers of access to care for patients with pancreatic cancer
- Analyze the impact of novel neoadjuvant, adjuvant and systemic therapy treatments for pancreatic cancer
- Discuss the role of different chemotherapy and radiation therapy modalities for pancreatic cancer
- Compare and contrast the potential benefits of minimally invasive surgery in pancreatic cancer